Actively Recruiting
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
Led by JW Pharmaceutical · Updated on 2026-04-23
104
Participants Needed
1
Research Sites
54 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation clinical trial to evaluate the safety, pharmacokinetic and pharmacodynamics of JW0061 following topical application in Korean and Caucasians healthy adults.
CONDITIONS
Official Title
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Body weight between 50.0 kg and 90.0 kg, and BMI between 18.5 and 29.9 kg/m²
- Healthy adults determined by medical history, physical exam, and lab tests
- Able to provide written informed consent and willing to follow all study requirements
You will not qualify if you...
- Clinically significant scalp conditions that may affect safety assessments
- History of cancer within 5 years before screening
- History of allergy or hypersensitivity to the study drug or its components
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital Clinical Trial Center
Seoul, Seoul, South Korea, 110-744
Actively Recruiting
Research Team
S
Soyeon Jeong
CONTACT
I
Inyoung Park
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here